The expression of the nuclear matrix proteins NuMA, topoisomerase II-α, and -β in bone and osseous cell culture: Regulation by parathyroid hormone

Bone

Volumn 26, Issue 3, 2000, Pages 227-234

  Feister, H A ^a   Onyia, J E ^b   Miles, R R ^b   Yang, X ^b   Galvin, R ^b   Hock, J M ^b,c   Bidwell, J P ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Anabolic; Bone; Nuclear matrix; NuMA; Parathyroid hormone; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ISOENZYME; MATRIX PROTEIN; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE MARROW CELL; CARTILAGE CELL; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL SHAPE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, NUCLEAR; BONE AND BONES; CELL CYCLE; CELLS, CULTURED; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; ISOENZYMES; MALE; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033970074     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00269-0     Document Type: Article

References (52)

1. Aarden E.M., Nijweide P.J., van der Plas A., Alblas M.J., Mackie E.J., Horton M.A., Helfrich M.H. Adhesive properties of isolated chick osteocytes in vitro. Bone. 18:1996;305-313.
2. Adachi Y., Kas E., Laemmli U.K. Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions. Eur Mol Biol Org. 8:1989;3997-4006.
3. Arnett T.R., Dempster D.W. A comparative study of disaggregated check and rat osteoclasts in vitro effects of calcitonin and prostaglandins . Endocrinology. 120:1987;602-608.
4. Austin C.A., Marsh K.L. Eukaryotic DNA topoisomerase IIβ BioEssays. 20:1998;215-226.
5. Benya P.D. Modulation and reexpression of the chondrocyte phenotype mediation by cell shape and microfilament modification . Pathol Immunopathol Res. 7:1988;51-54.
6. Bidwell J.P., Alvarez M., Feister H., Onyia J., Hock J. Nuclear matrix proteins and osteoblast gene expression. J Bone Miner Res. 13:1998;155-167.
7. Bidwell J., Feister H., Swartz D., Onyia J., Holden J., Hock J. Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins. J Cell Biochem. 63:1996;374-383.
8. Bidwell J., van Wijnen A., Banerjee C., Fey E., Merriman H., Penman S., Stein J., Lian J., Stein G. Parathyroid-responsive modifications on the nuclear matrix of ROS 17/2.8 rat osteosarcoma cells. Endocrinology. 134:1994;1738-1744.
9. Bojanowski K., Maniotis A.J., Plisov S., Larsen A.K., Ingber D.E. DNA topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA. J Cell Biochem. 69:1998;127-142.
10. Compton D.A., Cleveland D.W. NuMA is required for the proper completion of mitosis. J Cell Biol. 120:1993;947-957.
11. Constantinou A.I., Vaughan A.T., Yamasaki H., Kamath N. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoiisomerase II alpha phosphorylation. Cancer Res. 56:1996;3192-4199.
12. Cosman F., Lindsay R. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int. 62:1998;475-480.
13. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocrine Rev. 14:1993;690-709.
14. Dhawan J., Lichtler A.C., Rowe D.W., Farmer S.R. Cell adhesion regulates pro-α1(I) collagen mRNA stability and transcription in mouse fibroblasts. J Biol Chem. 266:1991;8470-8475.
15. Diegelmann R.F., Peterkofsky B. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubule disruptive drugs. Proc Natl Acad Sci USA. 69:1972;892-896.
16. Dobnig H., Turner R. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 136:1995;3632-3638.
17. Dynlacht, J. R., Henthorn, J., O'Nan, C., Dunn, S. T., and Story, M. D. Flow cytometric analysis of nuclear matrix proteins: method and potential applications. Cytometry 24:348-259; 1996.
18. Egan J.J., Grononwicz G., Rodan G. Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells mediation by cyclic AMP . J Cell Biochem. 45:1991;101-111.
19. Feister H.A., Swartz D., Odgren P.R., Holden J., Hock J.M., Onyia J., Bidwell J.P. Topoisomerase II expression in osseous tissue. J Cell Biochem. 67:1997;451-465.
20. Fey E.G., Wan J., Penman S. The epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold three-dimensional organization and protein composition . J Cell Biol. 19:1984;1973-1984.
21. Getzenberg R.H., Konety B.R., Oeler T.A., Quigley M.M., Hakam A., Becich M.J., Bahnson R.R. Bladder cancer-associated nuclear matrix proteins. Cancer Res. 56:1998;1690-1694.
22. Giaccone G. DNA topoisomerases and topoisomerase inhibitors. Path Biol. 42:1994;346-352.
23. Goswami P.C., Roti Roti J.L., Hunt C.R. The cell cycle-coupled expression of topoisomerase IIα during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol Cell Biol. 16:1996;1500-1508.
24. Gunness-Hey M., Hock J.M. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metabolic Bone Dis Related Res. 5:1984;177-181.
25. Heck M.M.S., Hittelman W.N., Earnshaw W.C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA. 85:1988;1086-1090.
26. Hock J.M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 7:1992;65-72.
27. Huang S., Chen C.S., Ingber D.E. Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell. 9:1998;3179-3193.
28. Junqueira L.C., Carneiro J., Kelley R.O. Basic Histology. 9th ed. 1998;Appleton & Lange.
29. Lelievre S.A., Weaver V.M., Nickerson J.A., Larabell C.A., Bhaumik A., Petersen O.W., Bissell M.J. Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proc Natl Acad Sci USA. 95:1998;14711-14716.
30. Liu F., Malaval L., Aubin J.E. The mature osteoblast phenotype is characterized by extensive plasticity. Exp Cell Res. 232:1997;97-105.
31. Lormi A., Marie P.J. Changes in cytoskeletal proteins in response to parathyroid hormone and 1,25-dihydroxyvitamin D in human osteoblastic cells. Bone Miner. 10:1990;1-12.
32. Mancini M.A., Dacheng H., Ouspenski I.I., Brinkley B.R. Dynamic continuity of nuclear and mitotic matrix proteins in the cell cycle. J Cell Biochem. 62:1996;158-164.
33. McDougall S., Fu Y.H., Lowe G.N., Williams A., Polendo R., Benya P.D., Iida-Klein A., Fang M.A., Hahn T.J. Surface adhesion-mediated regulation of chondrocyte-specific gene expression in the nontransformed RCJ 3.1C5.18 rat chondrocyte cell line. J Bone Miner Res. 11:1996;1130-1138.
34. Merdes A., Cleveland D.W. The role of NuMA in the interphase nucleus. J Cell Sci. 111:1998;71-79.
35. Nakajima T., Morita K., Ohi N., Arai T., Nozaki N., Kikuchi A., Osaka F., Yamao F., Oda K. Degradation of topoisomerase IIα during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J Biol Chem. 271:1996;24842-24849.
36. Nakamura I., Takahashi N., Sasaki T., Jimi E., Kurokawa T., Suda T. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J Bone Miner Res. 11:1996a;1873-1879.
37. Nakamura I., Gailit J., Sasaki T. Osteoclast integrin alphaVbeta3 is present in the clear zone and contributes to cellular polarization. Cell Tissue Res. 286:1996b;507-515.
38. Kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology. 138:1997;1995-2004.
39. Onyia J.E., Miller B., Hulman J., Liang J., Galvin R., Frolik C., Chandrasekhar S., Harvey A.K., Bidwell J., Herring J., Hock J.M. Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. Bone. 20:1997;93-100.
40. Onyia J.E., Bidwell J.P., Herring J., Hulman J., Hock J.M. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone. 17:1995;479-484.
41. Pavalko F.M., Chen N.X., Turner C.H., Burr D.B., Atkinson S., Hsieh Y.F., Qiu J., Duncan R.L. Fluid shear-induced mechanical signaling in MC3T3-E1 osteoblasts requires cytoskeleton-integrin interactions. Am J Physiol. 275:(6 Pt 1):1998;C1591-C1601.
42. Prosperi E., Negri C., Bottiroli G., Astaldi Ricotti G.C.B. Immunocytometric determination of the α and β isoforms of human DNA topoisomerase II influence of different fixatives . Analytical Cell Pathol. 10:1996;137-148.
43. Rawlinson S.C., Pitsillides A.A., Lanyon L.E. Involvement of different ion channels in osteoblasts' and osteocytes' early responses to mechanical strain. Bone. 19:1996;609-614.
44. Scherft J.P., Heersche J.N.M. Accumulation of collagen containing vacuoles in osteoblasts after administration of colchicine. Cell Tissue Res. 157:1975;353-365.
45. Schmidt, I. U., Dobnig, H., Turner, R. T. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology 136:5127-2134; 1995.
46. Tanaka-Kamioka K., Kamioka H., Ris H., Lim S.S. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Reds. 13:1998;1555-1568.
47. Torrungruang K., Feister H.A., Swartz D., Hancock E.G., Hock J., Bidwell J.P. Parathyroid hormone regulates the expression of the nuclear mitotic apparatus protein in the osteoblast-like cells, ROS 17/2.8. Bone. 22:1998;317-324.
48. Turner R.T., Evans G.L., Cavolina J.M., Halloran B., Morey-Holton E. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariecotmized rats. Endocrinology. 139:1998;4086-4091.
49. Wang Z., Dröge P. Differential control of transcription-induced and overall DNA supercoiling by eukaryotic topoisomerases in vitro. Eur Mol Biol Org. 15:1996;581-589.
50. Wells N.J., Fry A.M., Guano F., Norbury C., Hickson I.D. Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C. J Biol Chem. 270:1995;28357-28363.
51. Zeng C., He D., Berget S.M., Brinkley B.R. Nuclear-mitotic apparatus protein A structural protein interface between the nucleoskeleton and RNA splicing . Proc Natl Acad Sci USA. 91:1994a;1505-1509.
52. Zeng C., He D., Brinkley B.R. Localization of NuMA protein isoforms in the nuclear matrix of mammalian cells. Cell Motil Cytoskel. 29:1994b;167-176.